Global Galectin Inhibitor Therapeutics Market Report By Indication (Fibrosis,Cancer immunotherapy,Dermatology,Others), By Route of Aministration (Oral,Parenteral,Others), By End-Users (Hospitals,Homecare,Specialty Clinics,Others), By Distribution Channel (hospital pharmacy,online pharmacy,retail pharmacy) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Galectin Inhibitor Therapeutics Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213815

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Galectin Inhibitor Therapeutics Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.

Galectin inhibitor therapeutics are potential drugs used in treating inflammatory disorders and in cancer immunotherapy. Galectin inhibitors enhance the immune system function to fight against cancer cells, increase the tumor-infiltrating lymphocytes, reduce lung metastases, and reduce tumor vasculature. Galectins are a subfamily of lectin proteins present in human tissue and blood. They act as a biomarker for several chronic diseases such as cardiac insufficiency, diabetes, rheumatoid arthritis, asthma, chronic inflammatory severe skin diseases, including plaque psoriasis and atopic dermatitis, and liver cirrhosis. Extensively used in oncology treatment, galectin inhibitors, along with chemotherapy and radiotherapy, improves the efficacy of treatment of various neoplasms.

Market Dynamics

The great potential of galectin inhibitor therapeutics in cancer treatment, fibrosis, and cardiovascular diseases is the primary stimulant anticipated to drive this market’s growth. The attractive therapeutic opportunity offered by these anti-migratory, anti-invasive, and anti-angiogenic galectin inhibitors in treating several chronic diseases will further propel market growth. The emergence of galectin protein as a significant focus of research and pharmaceutical development for a wide range of medical conditions will boost the market growth. This market’s critical challenges are the complexities of developing effective therapeutics and the delivery of intact galectin to the desired site.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of galectin inhibitor therapeutics.

Market Segmentation

This section of the galectin inhibitor therapeutics market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Indication

Fibrosis
Cancer immunotherapy
Dermatology
Others

By Route of Aministration

Oral
Parenteral
Others

By End-Users

Hospitals
Homecare
Specialty Clinics
Others

By Distribution Channel

hospital pharmacy
online pharmacy
retail pharmacy

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for Galectin Inhibitor Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Galectin Inhibitor Therapeutics Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the galectin inhibitor therapeutics market include Galectin Therapeutics Inc, MandalMed, Inc, G3 Pharmaceuticals, Angion, iTeos, GlycoMimetics, and Galecto Biotech among others.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot

3 . GALECTIN INHIBITOR THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Indication
           3.7.2 By Route of Aministration
           3.7.3 By End Users
           3.7.4 By Distribution Channel
           3.7.5 By Region

4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY INDICATION
       6.1 Overview by Indication
       6.2 Historical and Forecast Data
       6.3 Analysis by Indication
       6.4 Fibrosis Market by Regions
       6.6 Cancer immunotherapy Market by Regions
       6.5 Dermatology Market by Regions
       6.7 Others Market by Regions

7 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY ROUTE OF AMINISTRATION
       7.1 Overview by Route of Aministration
       7.2 Historical and Forecast Data
       7.3 Analysis by Route of Aministration
       7.4 Oral Market by Regions
       7.5 Parenteral Market by Regions
       7.6 Others Market by Regions

8 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY END USERS
       8.1 Overview by End Users
       8.2 Historical and Forecast Data
       8.3 Analysis by End Users
       8.4 Hospitals Market by Regions
       8.5 Homecare Market by Regions
       8.6 Specialty Clinics Market by Regions
       8.7 Others Market by Regions

9 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       9.1 Overview by Distribution Channel
       9.2 Historical and Forecast Data
       9.3 Analysis by Distribution Channel
       9.4 Hospital Pharmacy Market by Regions
       9.5 Online Pharmacy Market by Regions
       9.6 Retail Pharmacy Market by Regions

10 . GLOBAL GALECTIN INHIBITOR THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America
           10.3.1. Overview, Historic and Forecast Data
           10.3.2. North America By Segment
           10.3.3. North America By Country
           10.3.4. United State
           10.3.5. Canada
           10.3.6. Mexico
       10.4. Europe
           10.4.1. Overview, Historic and Forecast Data
           10.4.2. Europe by Segment
           10.4.3. Europe by Country
           10.4.4. United Kingdom
           10.4.5. France
           10.4.6. Germany
           10.4.7. Italy
           10.4.8. Russia
           10.4.9. Rest Of Europe
       10.5. Asia Pacific
           10.5.1. Overview, Historic and Forecast Data
           10.5.2. Asia Pacific by Segment
           10.5.3. Asia Pacific by Country
           10.5.4. China
           10.5.5. India
           10.5.6. Japan
           10.5.7. South Korea
           10.5.8. Australia
           10.5.9. Rest Of Asia Pacific
       10.6. Latin America
           10.6.1. Overview, Historic and Forecast Data
           10.6.2. Latin America by Segment
           10.6.3. Latin America by Country
           10.6.4. Brazil
           10.6.5. Argentina
           10.6.6. Peru
           10.6.7. Chile
           10.6.8. Rest of Latin America
       10.7. Middle East & Africa
           10.7.1. Overview, Historic and Forecast Data
           10.7.2. Middle East & Africa by Segment
           10.7.3. Middle East & Africa by Country
           10.7.4. Saudi Arabia
           10.7.5. UAE
           10.7.6. Israel
           10.7.7. South Africa
           10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE GALECTIN INHIBITOR THERAPEUTICS COMPANIES
       11.1. Galectin Inhibitor Therapeutics Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments

12 . COMPANY PROFILES OF GALECTIN INHIBITOR THERAPEUTICS INDUSTRY
       12.1. Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Galectin Therapeutics Inc.
           12.3.1. Company Overview
           12.3.2. Financials
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. MandalMed Inc.
           12.4.1. Company Overview
           12.4.2. Financials
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. G3 Pharmaceuticals
           12.5.1. Company Overview
           12.5.2. Financials
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Angion
           12.6.1. Company Overview
           12.6.2. Financials
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. iTeos
           12.7.1. Company Overview
           12.7.2. Financials
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. GlycoMimetics
           12.8.1. Company Overview
           12.8.2. Financials
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. Galecto Biotech
           12.9.1. Company Overview
           12.9.2. Financials
           12.9.3. Products
           12.9.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Galectin Inhibitor Therapeutics Report
Market Research Process
Market Research Methodology
Global Galectin Inhibitor Therapeutics Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by Route of Aministration
Market Attractiveness Analysis by End Users
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Segment Analysis 1 (USD MN)
Fibrosis Market by Geography (USD MN)
Cancer immunotherapy Market by Geography (USD MN)
Dermatology Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by Route of Aministration (USD MN)
Oral Market by Geography (USD MN)
Parenteral Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by End Users (USD MN)
Hospitals Market by Geography (USD MN)
Homecare Market by Geography (USD MN)
Specialty Clinics Market by Geography (USD MN)
Others Market by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacy Market by Geography (USD MN)
Online Pharmacy Market by Geography (USD MN)
Retail Pharmacy Market by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "